Pay in 4 interest-free payments of $7.16 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Lancet 376 , 419430 (2010)
The trial involved 1879 patients with inadequate glycemic control on metformin monotherapy, who were randomly assigned to receive tirzepatide at doses of 5 mg, 10 mg, or 15 mg, or semaglutide at a dose of 1 mg.After 40 weeks of treatment, all doses of tirzepatide were found to be noninferior and superior to semaglutide in terms of reducing glycated hemoglobin (HbA1c) levels
The platform provides evidence-based guides, detailed protocols, and a community of experienced researchers who help navigate exactly these kinds of nuanced safety questions
Shipping times vary between pharmacies
Hers runs primarily on an asynchronous model
Exceeds a standard 1 mL U-100 syringe
US$ 29.72
US$ 27.33
US$ 22.66
US$ 22.61
US$ 28.58
